Investors

Board of Directors/Company Secretary
Charter Documents of Africure
Annual Meeting of Shareholders/Special Meeting of Shareholders

Board and Committee Charters

Audit and Risk
Code of Ethics & related policies
Corporate Governance committee charter
Family Employment plan
Remuneration and Nomination

Financials

Annual Report of 2017-2018
Annual Report of 2018-2019
Annual Report of 2019-2020
Annual Report of 2021-2022
Annual Report of 2022-2023
Audited Financial Statement for 2020-2021

Corporate Governance

Corporate Governance Report for FY2020-2021

Announcements

Abridged Audited/Un-audited consolidated financial statement

Financial Statement FY 2023-2024
Q3-FY-23-24
Q2-FY-23-24
Q1-FY-23-24
Financial Statement FY 2022-2023
Q4-FY22-23
Q3-FY22-23
Q2-FY22-23
Q1-FY22-23
Financial Statement FY 2021-2022
Q4-FY21-22
Q3-FY21-22
Q2-FY21-22
Q1-FY21-22

Others

Extension of Africure Mauritius Board Meeting Q4 FY23-24
Corporate Announcement
Notice of Annual General Meeting of Shareholders FY 21-22
Listing on Stock Exchange of Mauritius
Extension of Deadline to release unaudited financial results ended December 2022
Extension of Africure Mauritius Board Meeting Q1-23-24
Availability of 31.06.23 results announcement
Notice of Annual General Meeting of Shareholders FY 22-23
Extension of Africure Mauritius Board Meeting Q3 FY 23-24

We can do a lot for you, share with us what you can do for us...
on info@africurepharma.com